EFOR
Everforth, Inc.NYSETECHNOLOGYINFORMATION TECHNOLOGY SERVICES
Key Statistics
Market Cap
$850.34M
P/E Ratio
9.43
EPS
$2.20
Beta
0.46
52W High
$60.75
52W Low
$18.50
50-Day MA
$36.16
200-Day MA
$45.40
Dividend Yield
—
Profit Margin
2.47%
Forward P/E
7.49
PEG Ratio
0.64
About Everforth, Inc.
Efoora Inc. develops rapid diagnostic tests and biosensors for testing and diagnosing diseases including HIV, Hepatitis B and C, malaria, pregnancy, bovine spongiform encephalopathy (BSE), and chronic wasting disease (CWD). The company is headquartered in Buffalo Grove, Illinois.
Fundamentals
| Revenue (TTM) | $3.98B |
| Gross Profit (TTM) | $1.14B |
| EBITDA | $356.90M |
| Operating Margin | 4.18% |
| Return on Equity | 5.48% |
| Return on Assets | 4.07% |
| Revenue/Share (TTM) | $93.00 |
| Book Value | — |
| Price-to-Book | 0.49 |
| Price-to-Sales (TTM) | 0.21 |
| EV/Revenue | 0.55 |
| EV/EBITDA | 6.69 |
| Quarterly Earnings Growth (YoY) | -72.80% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $41.00M |
| Float | $39.42M |
| % Insiders | 3.37% |
| % Institutions | 100.57% |
Analyst Ratings
Consensus ($33.33 target)
3
Buy2
Hold2
SellMore TECHNOLOGY Stocks
Data last updated: 5/5/2026